Sahajanand Medical Technologies Pvt. Ltd. - Product Pipeline Analysis by GlobalData

VIEWS: 42 PAGES: 37

Sahajanand Medical Technologies Pvt. Ltd. - Product Pipeline Analysis

Summary

This report is a source for data, analysis and actionable intelligence on the Sahajanand Medical Technologies Pvt. Ltd. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligib

More Info
									          Sahajanand Medical Technologies Pvt. Ltd. - Product Pipeline Analysis
     Reference Code: GDMEPH8523PD                                                                                                            Publication Date: NOV 2010



     Company Snapshot                                                              Company Overview
     Key Information
                                                                                    Sahajanand Medical Technologies Pvt. Ltd. (SMTPL) is a part of Sahajanand Group
     Sahajanand Medical Technologies Pvt. Ltd., Key Facts                           Company. It is engaged in the research, design, development, manufacture and
                                                                                    marketing of intravascular products for the cardiac markets. SMTPL develops drug
     Web Address                            www.smtpl.com                           eluting stents which are utilized in the treatment of coronary artery disease through
                                                                                    percutaneous intervention. The company’s product portfolio includes paclitaxel-eluting
     Number of Employees                    400                                     stents and sirolimus eluting stents, which are designed to prevent in-stent restenosis
     Industry                               Pharmaceuticals and                     in percutaneous coronary angioplasty. Its millennium stent is a tubular balloon
                                            Healthcare-                             expandable coronary Stent designed to be crimped onto a PTCA balloon catheter.
     Source:Primary / Secondary Research
     GlobalData



     Sahajanand Medical Technologies Pvt. Ltd. Pipeline Products

      Sahajanand Medical Technologies Pvt. Ltd. Key                                Sahajanand Medical Technologies Pvt. Ltd. Key Pipeline Products by
      Pipeline Products by Equipment Type                                          Therapy Area
     Equipment Type                       No of Products                           Therapy Area                                       No of Products
     Interventional Cardiology                   5                                 Atherosclerosis                                           4
                                                                                   Restenosis                                                1
     Source: Primary / Secondary Research                                           Source: Primary / Secondary Research
     GlobalData                                                                     GlobalData




     Sahajanand Medical Technologies Pvt. Ltd. Key Pipeline Products by Development Stage

     Developmental Stage                                                                                                   No of Products
     Clinicals                                                                                                                    4
     Pre-Clinicals                                                                                                               -
     Early development                                                                                                           1
     No Specific Phase                                                                                                           2
                                                                        Source: Primary / Secondary Research
     GlobalData
     Note : (-) indicates 'Not Available'



     Sahajanand Medical Technologies Pvt. Ltd. Key Pipeline Products by Trial Phase

     Trial Phase                                                                                                           No of Products
     Phase IV                                                                                                                     2
     Phase III                                                                                                                   -
     Phase II                                                                                                                    1
     Phase I                                                                                                                     -
     Source: Primary / Secondary Research
     GlobalData
     Note : (-) indicates 'Not Available'




Sahajanand Medical Technologies Pvt. Ltd. - Product Pipeline Analysis                                                                           Reference Code: GDMEPH8523PD

Source : www.globalcompanyintelligence.com                                                                                                                                   Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 3
     List of Figures......................................................................................................................................................................................................................................................................... 4
     Key Facts ............................................................................................................................................................................................................................................................................... 5
     Sahajanand Medical Technologies Pvt. Ltd. - Major Products and Services......................................................................................................................................................................... 6
           Sahajanand Medical Technologies Pvt. Ltd. Pipeline Products by Equipment Type ...................................................................................................................................................... 7
           Sahajanand Medical Technologies Pvt. Ltd. Pipeline Products by Development Stage ................................................................................................................................................. 9
           Sahajanand Medical Technologies Pvt. Ltd. Pipeline Products by Therapy Area......................................................................................................................................................... 11
           Sahajanand Medical Technologies Pvt. Ltd. Pipeline Products by Trial Phase ............................................................................................................................................................ 13
           Sahajanand Medical Technologies Pvt. Ltd. Pipeline Products by Milestone Summary............................................................................................................................................... 15
           Coronnium Coronary Stent System ............................................................................................................................................................................................................................... 17
                 Product Status......................................................................................................................................................................................................................................................... 17
                 Product Description ................................................................................................................................................................................................................................................. 17
           Genistein-coated balloon catheter ................................................................................................................................................................................................................................. 17
                 Product Status......................................................................................................................................................................................................................................................... 17
                 Product Description ................................................................................................................................................................................................................................................. 17
                 Product Patent Details ............................................................................................................................................................................................................................................ 17
           Infinnium Paclitaxel Eluting Coronary Stent System...................................................................................................................................................................................................... 19
                 Product Status......................................................................................................................................................................................................................................................... 19
                 Product Description ................................................................................................................................................................................................................................................. 19
                 Infinnium Paclitaxel Eluting Coronary Stent System Clinical Trial .......................................................................................................................................................................... 19
           Supralimus Sirolimus-Eluting Coronary Stent................................................................................................................................................................................................................ 24
                 Product Status......................................................................................................................................................................................................................................................... 24
                 Product Description ................................................................................................................................................................................................................................................. 24
                 Product Milestone ................................................................................................................................................................................................................................................... 24
                 Supralimus Sirolimus-Eluting Coronary Stent Clinical Trial .................................................................................................................................................................................... 25
           Supralimus-Core............................................................................................................................................................................................................................................................ 30
                 Product Status......................................................................................................................................................................................................................................................... 30
                 Product Description ................................................................................................................................................................................................................................................. 30
                 Supralimus-Core Clinical Trial................................................................................................................................................................................................................................. 31
     Sahajanand Medical Technologies Pvt. Ltd. - Key Competitors .......................................................................................................................................................................................... 34
     Sahajanand Medical Technologies Pvt. Ltd. - Key Employees............................................................................................................................................................................................ 35
     Sahajanand Medical Technologies Pvt. Ltd. - Locations And Subsidiaries ......................................................................................................................................................................... 36
           Head Office.................................................................................................................................................................................................................................................................... 36
           Other Locations & Subsidiaries ..................................................................................................................................................................................................................................... 36
     Appendix .............................................................................................................................................................................................................................................................................. 37
           Methodology .................................................................................................................................................................................................................................................................. 37
           About GlobalData .......................................................................................................................................................................................................................................................... 37
           Contact Us ..................................................................................................................................................................................................................................................................... 37
           Disclaimer ............................................................................................
								
To top